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1. Introduction
Food safety authorities aim at protecting the health of 
consumers by taking measures to avoid exposure of the 
population to harmful levels of these compounds. The 
measures should ensure that exposure of the population 
is below health-based guidance values, such as an acute 
reference dose or tolerable daily or weekly intake. The 
measures are preferably based on science-based risk 
evaluations from competent food safety authorities. Risk 
assessment studies, composed of hazard identification, 
characterisation and exposure assessment, are an integral 
part of these evaluations (Brera et al., 2014; FAO/WHO, 
2012; Marin et al., 2013; Van Egmond et al., 2007).
Food safety authorities of EU Member States are obliged to 
monitor the occurrence of harmful compounds in food by 
implementing risk-based monitoring programs (EC, 2004). 
Results from long-term monitoring of the occurrence of 
undesirable substances in food can also provide input for 
a trend analysis on levels and exposure in order to evaluate 
the effectiveness of implemented measures, to discover 
unknown sources of mycotoxins, and to give insight in 
changing trends in contamination of crops.
Food can be contaminated with a mixture of mycotoxins, 
natural toxins produced by fungal species in all parts of 
the world. Fungal invasion and mycotoxins production 
can take place both in the field and/or during storage of 
the crops (Han et al., 2014). The actual contamination 
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Abstract
In this review, five strategies to estimate mycotoxin exposure of a (sub-)population via food, including data collection, 
are discussed with the aim to identify the added values and limitations of each strategy for risk assessment of these 
chemicals. The well-established point estimate, observed individual mean, probabilistic and duplicate diet strategies 
are addressed, as well as the emerging human biomonitoring strategy. All five exposure assessment strategies allow 
the estimation of chronic (long-term) exposure to mycotoxins, and, with the exception of the observed individual 
mean strategy, also acute (short-term) exposure. Methods for data collection, i.e. food consumption surveys, 
food monitoring studies and total diet studies are discussed. In food monitoring studies, the driving force is often 
enforcement of legal limits, and, consequently, data are often generated with relatively high limits of quantification 
and targeted at products suspected to contain mycotoxin levels above these legal limits. Total diet studies provide 
a solid base for chronic exposure assessments since they provide mycotoxin levels in food based on well-defined 
samples and including the effect of food preparation. Duplicate diet studies and human biomonitoring studies reveal 
the actual exposure but often involve a restricted group of human volunteers and a limited time period. Human 
biomonitoring studies may also include exposure to mycotoxins from other sources than food, and exposure to 
modified mycotoxins that may not be detected with current analytical methods. Low limits of quantification are 
required for analytical methods applied for data collection to avoid large uncertainties in the exposure due to high 
numbers of left censored data, i.e. with levels below the limit of quantification.
Keywords: exposure assessment, food consumption, mycotoxins, human biomonitoring, total diet study, duplicate diet 
study, food monitoring
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levels are determined by complex interaction among fungal 
species, plant cultivars and environmental factors (Battilani 
et al., 2012; Van der Fels-Klerx, 2014). The occurrence of 
fungi on crops varies between geographic regions, climatic 
conditions and pre- and post-harvest management (De 
Rijk et al., 2015). The types and levels of mycotoxins in 
food can therefore vary considerably. Industrial processes 
and household preparation processes, such as cleaning or 
peeling, may furthermore alter the profile and the levels of 
mycotoxins in consumed food (Cano-Sancho et al., 2013; 
Meca et al., 2013; Tittlemier et al., 2014; Vidal et al., 2014).
International trade of food and feed adds variation to the 
exposure to mycotoxins and introduces extra challenges to 
assess the exposure (Cressey, 2009; Kendra and Dyer, 2007). 
Additionally, dietary exposure varies between geographic 
regions due to variability in the diets consumed and specific 
individual consumption patterns (Boon et al., 2009; Brera 
et al., 2014; EFSA, 2014b; FAO/WHO, 2012).
The present paper will describe and discuss five strategies 
applied in exposure assessments of mycotoxins. First, 
four data collection studies are described, followed by the 
description of the use of these data in four well established 
exposure assessment strategies. Secondly, a new strategy for 
exposure assessment, human biomonitoring, is described. 
Benefits and limits of all five exposure assessment strategies 
are discussed in the final chapter.
2. Data collection studies for exposure 
assessment
Application of the four well-established exposure assessment 
strategies described in Section 3, for the assessment of 
the dietary exposure to mycotoxins, require data on food 
consumption as well as data on levels of mycotoxins in 
food. Table 1 presents a schematic overview of the food 
consumption and data collection studies for these well-
established exposure assessment strategies.
Table 1. Characteristics of: (1) study design; (2) sample number and analysis; (3) ethical issues; (4) costs; and (5) ability to use 
provided samples for other contaminants.
Data collection study Characteristics
Food consumption surveys 
(FCSs)
1. Complex study design.
2. Large number of subjects required, including subgroups in the population.
3. Volunteers involved, requiring ethical approval and management of privacy data.
4. High costs for collection of data and processing of data.
5.  Data can be used for exposure assessment to food chemicals and intake assessment to nutrients, both acute and 
chronic (if covering more than one day per subject).
Food monitoring studies 1. Simple study design.
2.  Large number of analytical samples, often from routine monitoring (official control), often analysed with multi-
methods with relatively high limits of quantification or reporting limits; no dilution of samples.
3. No volunteers involved.
4.  High costs for sample collection, relatively low analysis costs per sample/mycotoxin. Primary aim in general is 
compliance checks, data from this can be used for exposure assessment studies without additional costs.
5.  Samples can be used for analysis of other food chemicals and to estimate acute and chronic exposure to these 
compounds.
Total diet studies 1. Initial study design complex but can be re-used in follow-up studies.
2.  Samples are pooled per food category, resulting in dilution of higher contaminated samples; sensitive analysis 
required to achieve quantifiable results.
3.  No volunteers involved; possibly ethical approval required when investigating diets of ethical groups in the 
population.
4. High costs for the initial design of the study; high costs for sample collection, preparation and analysis.
5.  Samples can be used for other food chemicals but only when the study design is suitable for this topic (so called 
total diet-like studies); only allows estimation of chronic exposure to contaminants.
Duplicate diet studies 1. Simple study design.
2.  Limited number of samples because all foods are pooled into one sample and small sample size; sensitive analysis 
required to achieve quantifiable results.
3.  A representative group of reliable volunteers must be identified; ethical approval is required and privacy must be 
managed; sample collection puts a high burden on the volunteers.
4. High costs for sample preparation; high costs for studies; high costs for processing of food diaries.
5.  Samples may be used for analysis of chemicals in food; allows estimation of chronic (if covering more than one day 
per subject) and acute exposure to contaminants.
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Food consumption surveys
The amount of a single food ingredient consumed influences 
the potential dietary exposure of humans to mycotoxins 
(Brera et al., 2014; Cressey and Reeve, 2013; EFSA, 2014b; 
O’Mahony and Vilone, 2013). Data on food consumption 
of a population are collected via questionnaires from 
volunteers and, ideally, at the individual level, at a high 
level of detail, and covering at least two days. At a national 
level, such databases are widely used to assess the dietary 
exposure to mycotoxins by the population (Boon et al., 
2009; Sprong et al., 2016b). At the international level, 
various databases are available for exposure assessment. 
The situation in the EU is assessed by the European Food 
Safety Authority (EFSA), while the Food and Agriculture 
Organisation (FAO) of the United Nations evaluates the 
global food situation, including countries with insufficient 
food supplies (EFSA, 2015a; FAO/WHO, 2015).
In 2011, EFSA introduced the Comprehensive European 
Food Consumption Database, hereafter called EFSA 
Comprehensive Database (EFSA, 2011d). The various EU 
Member States provide(d) EFSA with data from their most 
recent national dietary surveys, at the level of the individual 
consumer. In addition, the food classification system 
‘FoodEx1’ was developed by EFSA to codify all foods and 
beverages present in the database. FoodEx1 is a hierarchical 
system based on 20 main food categories that are further 
divided into subgroups up to a maximum of 4 levels. In 
2015, the EFSA Comprehensive Database was updated 
with additional, up-to-date, food consumption data (EFSA, 
2015b). These data were coded with an upgraded version of 
EFSA’s food classification and description system, FoodEx2, 
which enables more precise reporting of consumption 
patterns. The FoodEx1 database, up to now used by EFSA, 
includes food consumption data concerning infants, 
toddlers, children, adolescents, adults, elderly and very 
elderly from 32 different dietary surveys carried out in 22 
different Member States. Summary statistics are calculated 
and are available at the EFSA website (EFSA, 2015a). These 
statistics include the total number of individuals per survey 
and age class and, for all four levels of FoodEx1, per age 
class and survey, the total number of consumers, and 
the mean, the median and the standard deviation of the 
consumption, as well as low and high percentiles. Food 
consumption statistics are reported both in grams per day 
and in grams per kg body weight per day, for both chronic 
and acute consumption, and for both the total population 
and consumers only (i.e. those that reported consumption of 
the specific food product on the one or more days included 
in the survey). These summary statistics can be used as a 
quick screening tool to assess chronic and acute exposure 
to hazardous substances. EFSA uses the detailed underlying 
consumption data at the individual level to perform more 
refined exposure assessments, both acute and chronic.
To assess global food intake, the WHO has managed since 
1976 a Food Contamination Monitoring and Assessment 
Programme, within the Global Environment Monitoring 
System, commonly known as GEMS/Food (WHO, 2015). 
WHO implements the programme in cooperation with a 
network of Collaborating Centres and recognised national 
institutions located all around the world. As part of its 
dietary exposure assessment mandate, GEMS/Food has 
developed supra-national model diets that are currently 
used for estimating dietary intake of various chemicals 
according to internationally accepted methodologies. 
Guidance documents have been developed for International 
Estimated Short-term Intake (IESTI) (FAO/WHO, 
2014), International Estimated Daily Intake (IEDI) and a 
harmonised Total Diet Study approach (see next section) 
(EFSA/FAO/WHO, 2011b). A monograph on the principles 
and methods for the risk assessment of chemicals in food 
has been published (FAO/WHO, 2009).
WHO and FAO have recently developed a new database 
for Individual Food Consumption Data. This Chronic 
Individual Food Consumption database – Summary 
statistics (CIFOCOss), is hosted by WHO and currently 
contains summary statistics of 37 surveys from 26 countries 
(only surveys with a survey duration of two days or more) 
(WHO, 2015). It has been developed to be used by FAO/
WHO scientific committees in particular for dietary 
exposure assessment purposes. It provides summary 
statistics at three levels of food categorisation and can 
therefore only be used for a rough indication of the dietary 
exposure at national level. CIFOCOss is continuously being 
expanded with data from additional food consumption 
surveys (WHO, 2015).
Data collection studies
Occurrence data on mycotoxins collected for exposure 
assessment purposes always require low limits of detection 
(LOQs) to prevent left-censored data or non-detects (‘below 
LOQ’). The assumption that the levels of mycotoxins in 
the samples with left censored data are as high as the 
LOQ, the upper bound principle, only allows worst case 
estimates (EFSA, 2010). This approach suffices if the margin 
between assumed exposure levels and levels causing the 
toxic effects is sufficiently large, but this is often not the 
case for mycotoxins. EFSA identified this problem with the 
genotoxic carcinogen sterigmatocystin (EFSA, 2013b) for 
which the upper bound approach led to a low margin of 
exposure, as a result from the fact that virtually all available 
data were left censored due to high LOQs. EFSA calculated 
a required LOQ of 1.5 µg/kg: based on consumption of the 
relevant food products, the level causing adverse effects in 
laboratory animals and the minimal required margin of 
exposure for genotoxic carcinogens. A dedicated survey 
was subsequently performed at an LOQ of 0.5 µg/kg and 
sterigmatocystin was detected in 10% of the 1,259 samples, 
ht
tp
://
w
w
w
.w
ag
en
in
ge
na
ca
de
m
ic
.c
om
/d
oi
/p
df
/1
0.
39
20
/W
M
J2
01
6.
20
45
 - 
M
on
da
y,
 Ju
ne
 1
9,
 2
01
7 
6:
56
:4
6 
A
M
 - 
U
ni
ve
rs
ite
it 
G
en
t I
P 
A
dd
re
ss
:1
57
.1
93
.1
87
.7
9 
M. de Nijs et al.
834 World Mycotoxin Journal 9 (5)
in most cases below 1 µg/kg (Mol et al., 2015). Besides the 
issue of low LOQs, another issue with certain mycotoxins 
is the high heterogeneity of the contamination which may 
result in a high uncertainty of the analysis results (higher 
than the measurement uncertainty of the analysis as such), 
but this clearly depends on the type of food product.
Food monitoring study
Food monitoring studies investigate the prevalence and 
concentration of contaminants, including mycotoxins, 
in single food ingredients or foods (Lopez et al., 2016b; 
Schwartzbord and Brown, 2015; Straumfors et al., 2015). 
This increases the chance of detecting the mycotoxins 
under investigation.
Samples in monitoring studies are typically collected 
randomly at various points in the supply chain, ideally 
assuring that a food product can be traced to the producer 
and repeatedly sampled over a longer time period. The 
aim of sampling within national (long-term) monitoring 
programs often is to check for compliance or law 
enforcement in risk-based designed studies (EC, 2004). This 
allows higher LOQs, often relatively close to the maximum 
legal limits (Sulyok et al., 2010). This may compromise the 
use of the data in exposure assessments, since samples 
taken in targeted studies may reflect higher occurrence 
and/or levels of mycotoxins than to which the consumer 
is exposed. The aim of the sampling should be clearly 
indicated to prevent potential bias. In addition, samples 
can also be collected in surveys (De Nijs et al., 2013; Lopez 
et al., 2016b; Sanders et al., 2014), certainly in case of non-
regulated mycotoxins. Results of such surveys are frequently 
published in literature, contrary to data from long-term 
monitoring programmes (Muller and Korn, 2013).
The relevance of occurrence data from food monitoring 
studies for exposure assessments is determined by the 
information accompanying the samples. Classification and 
description are important to derive exposure estimations 
for the general population as well as for sensitive groups in 
the population, such as infants or people with specific diets 
as in the case of celiac disease (EFSA, 2013c). Knowledge 
on geographic origin is of interest for trend analysis and for 
adjustments to risk-based monitoring programs. Sample 
size, sampling strategy and sample preparation must be 
documented since these may influence the exposure results 
(De Rijk et al., 2015; Garcia-Cela et al., 2013; Pichler, 2013; 
Spanjer et al., 2006).
In addition to confirmatory methods, also relatively simple 
screening methods like immunoassays may be used in food 
monitoring studies. Screening methods are by definition 
unsuitable to identify the target compound but can be used 
to exclude their presence above a certain cut-off value. 
Data obtained with such screening methods require careful 
evaluation before use in exposure assessments.
Food monitoring studies analyse mycotoxin levels often 
in raw food ingredients. Occurrence data from these 
sources require a processing factor when used in exposure 
assessments, to translate the levels to contamination levels 
in the ready-to-eat foods. Mycotoxins can be lost after 
peeling (e.g. vegetables), cleaning and sorting (e.g. peanuts 
(Torres et al., 2014)) and, in case of cereals, after a certain 
degree of debranning, i.e. (partly) removing the outer 
layer of the kernel which is often more contaminated with 
mycotoxins. Common processing, such as fermentation, 
heating and household preparation may have a further 
effect. In their exposure assessment on deoxynivalenol 
(DON), Boon et al. (2009) applied a processing factor to 
occurrence data in raw wheat and rice samples to estimate 
the levels in prepared pasta and rice.
Total diet study
In total diet studies, food samples representing the whole 
diet and prepared as consumed are analysed for food 
chemicals. Samples are collected, prepared and pooled 
into composite samples per food category (EFSA/FAO/
WHO, 2011b; Marin et al., 2013). Due to the pooling of 
samples, results are not appropriate for compliance or law 
enforcement, although they may trigger follow-up studies. 
Samples collected within a total diet study should cover at 
least one of the two main aspects of representativeness: 
seasonality and geographical variation (EFSA/FAO/WHO, 
2011a). The geographical coverage is important because 
of potential regional differences in dietary patterns and in 
the levels of mycotoxins in foods. Even if no differentiation 
is made in the exposure assessment between regions, the 
sampling has to cover potential geographical differences. 
For small countries like the Netherlands, this might be 
less relevant (Sprong et al., 2016b), but for larger countries 
with different climate zones of very different ethnic groups 
or large variations in consumption patterns, this must be 
carefully addressed (Australia New Zealand Food Standards, 
2011). For locally produced foods, it is important to ensure 
that discount shops, supermarkets and farmers’ markets are 
sampled proportionally to their market share. Seasonality 
should be addressed for foods in which the mycotoxin 
levels may vary due to climatic conditions (i.e. cereals) or 
seasonal supply variations.
The preparation of the food list is of paramount importance 
in total diet studies. The food list should cover around 90% 
of the food intake, should be as close as possible to the 
actual whole diet and should include beverages and drinking 
water (EFSA/FAO/WHO, 2011b). Representative food items 
should be identified and selected from food consumption 
data. Food processing and at-home food preparation, like 
addition of water, salt and use of cooking utensils, should 
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be selected for each type of food and should be as close as 
possible to the habits of the population. Finally, the degree 
of pooling into the composite samples should be determined 
according to the total diet study purposes. Pooling of 
the processed samples is an essential step and consists 
of creating a unique food sample (composite sample) for 
analysis. This is achieved by combining various individually 
prepared food items either of the same type (individual 
food approach; e.g. one apple sample made of different 
varieties of apples) or by mixing several different foods 
from the same food group (mixed food approach; e.g. one 
fruit sample made of different types of fruits like apple, 
pear or banana).
In a total diet-like study, the food items for which 
contamination levels of the relevant (group of) substances 
are expected are sampled separately (EFSA/FAO/WHO, 
2011a). So in case of patulin, apple products, being the main 
source of this mycotoxin (Beretta et al., 2000), should be 
sampled and combined into a separate composite sample, 
not containing other fruit products (Sprong et al., 2016b). 
The same applies to aflatoxin M1 which is only present 
in dairy products, while e.g. the occurrence of fumonisin 
B1 seems more limited to maize derived products and 
potentially wheat (Cendoya et al., 2014).
Total diet-like studies specifically designed for mycotoxin 
exposure were carried out in France in 2013 (Sirot et al., 
2013) and in the Netherlands in 2014 (Lopez et al., 2016a; 
Sprong et al., 2016a,b). In the French study, 1,319 food 
items were collected, prepared and pooled, resulting in 577 
composite samples for mycotoxin analysis. In the study in 
the Netherlands, 1,617 food items were pooled into 213 
sub-samples, which were further pooled proportionally 
according to the consumption habits of the population 
in the Netherlands, eventually resulting in 88 composite 
samples for analysis (Sprong et al., 2016b).
Foods contributing most to the exposure can be identified 
by combining the analysed levels in the total diet(-like) 
study with food consumption data (Cano-Sancho et al., 
2011; Leblanc et al., 2005; Sirot et al., 2013; Sprong et al., 
2016a; Vin et al., 2014). EFSA distinguishes two types of 
total diet study approaches: a total diet study for screening, 
consisting of a limited number of composite food samples 
representative for common food categories, and a total 
diet study for refined exposure assessment containing a 
large number of samples representative for smaller, more 
refined, food categories (EFSA/FAO/WHO, 2011a). If the 
screening indicates high exposures, further evaluation 
should be performed to identify its source.
Storage of the samples before and after preparation of 
composites must be assessed, but for mycotoxins this seems 
less of an issue since they are stable in samples stored in 
the freezer and during freeze drying. Due to pooling of 
samples, and thus dilution of the compounds of interest, a 
low LOQ must be aimed at. Although multi-methods can be 
applied to the more generic samples, the specific composite 
samples need dedicated analysis with lower LOQs. For 
instance, Lopez et al. (2016a) applied a dedicated method 
for trichothecenes using GC-MS/MS after derivatisation, 
which resulted in ten times lower LOQs than those obtained 
with multi-methods (Lopez et al., 2016a; Sirot et al., 2013).
No volunteers are involved in total diet(-like) studies and 
hence no ethical issues are involved in the collection of the 
samples. However, approval from the competent ethics 
commission might be required when the study aims at diets 
of specific ethical groups in the population.
Costs lay in the design of the study, the preparation of the 
samples and the analysis of the samples. Costs of analysis 
can be high due to the low LOQs required and can be 
50% of the total costs of the study (EFSA/FAO/WHO, 
2011b). However, once the total diet study is performed, 
the design can be used to repeat the study for follow-up 
studies, thereby reducing their costs considerably. Samples 
stored may allow trend analysis of known and emerging 
mycotoxins for risk management information. However, 
samples collected specifically for certain mycotoxins, may 
be less useful for other classes of mycotoxins or other 
contaminants, since these may occur in other specific 
products that were not sampled separately and/or may be 
volatile and therefore lost during freeze-drying.
Duplicate diet study
In duplicate diet studies, an exact copy of all the foods 
and drinks as consumed by one person in a certain time 
period, e.g. 24 hours, is collected by volunteers with an 
accompanying food diary. In duplicate diet studies carried 
out in the Netherland this typically yields about 300 g of 
freeze dried samples per person. These studies are used to 
measure the actual exposure of consumers to compounds 
of interest, including the effects of food processing and 
preparation (Jekel and Van Egmond, 2014; Vaessen and 
Schothorst, 1999). Since samples are a mix of the foods as 
consumed, the contamination can seldom be traced to a 
specific food ingredient or food which makes the method 
unsuitable for enforcement of legislation, but allows 
comparing exposure data with health-based guidance 
values.
Several alternatives of the duplicate diet study are known, 
such as the cyclic sub-portion duplicate diet, the sub-
population duplicate diet, targeted food duplicate diet 
and the total population diet (Tomerlin et al., 2002). In 
these alternatives only a portion of the diet is collected or 
foods are collected based on standardised or average diets. 
Duplicate diets collected per eating event (Melnyk et al., 
2012) allows the identification of a specific group of foods 
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responsible for the main exposure. For example aflatoxin 
M1 and fumonisins may occur more frequent in breakfast 
samples since dairy products (milk, yoghurt) and maize 
based cornflakes are, in many regions of the EU, consumed 
at breakfast. DON can be present in all meals containing 
cereal products, which are often consumed during the 
whole day in European type diets.
The study design is quite straightforward, but the sample 
collection and preparation are complex. As a result, 
duplicate diet studies are always limited in the number 
of participants and sampling days, which hampers the 
extrapolation of the results to larger populations.
The analysis of duplicate diets requires low LOQs due 
to dilution of the compounds in the sample (Jekel and 
Van Egmond, 2014). After homogenisation of the entire 
sample, it is typically freeze dried and stored in the freezer. 
Mycotoxins are stable under these conditions, which 
allows the collection of historic information (trends) when 
analysing emerging mycotoxins in the future. An example 
is the exposure assessment for T-2/HT-2 toxins in a study 
in the Netherlands (Jekel and Van Egmond, 2014).
The involvement of volunteers means that ethical issues 
must be addressed before the start of the collection. The 
actual collection of the duplicate diet typically involves 
the use of a cooled container which can be a burden to 
volunteers and may influence the diet consumed in the 
period of collection. Costs for collection of duplicate 
diets are high and only a limited number of samples can 
be collected. The latter reduces the costs for analysis but 
these can still be high due to the very low LOQs required.
3. Exposure assessment strategies
Exposure assessment is defined by the Food and Agriculture 
Organisation of the United Nations (FAO) and World Health 
Organisation (WHO) as the qualitative and/or quantitative 
evaluation of the likely intake of chemical agents via food 
as well as exposure from other sources if relevant (FAO/
WHO, 2008). For estimating the dietary exposure of 
humans to mycotoxins, information on prevalence and 
levels in foods are combined with consumption information 
(Brera et al., 2014; Cressey and Reeve, 2013; EFSA, 2014b). 
A schematic overview of the well-established exposure 
assessment strategies for among others mycotoxins is given 
in Figure 1 and the characteristics are described in Table 
2. Each strategy yield unique information and has its own 
merits and challenges. Depending on the approach, these 
strategies may be used to estimate either acute exposure, 
i.e. during a period of 24 hours or less, or chronic exposure, 
i.e. over a longer period of time: from a couple of months 
up to several years.
Point estimate
In point estimate assessments, a single mycotoxin 
concentration value is combined with a single input 
parameter for consumption. The result is one single 
exposure estimate with a high degree of uncertainty. The 
input for concentration often comes from a food monitoring 
study or a total diet study. A mean or high consumption 
level from a food consumption survey is often used for 
input for consumption. If exposure via more than one food 
product is expected, the calculated exposures per food item 
can be combined to assess the total exposure.
Food consumption 
survey 
Food monitoring 
study 
Total diet 
study
Duplicate diet 
study 
Point estimate
Observed individual 
mean 
Dietary exposure using 
duplicate diet studies 
Data collection studies Possible exposure assessment strategies
Probabilistic approach
Figure 1. Overview of the methods for data collection and how these serve as input for different strategies to assess the dietary 
exposure. For total diet studies, the food list included should cover about 90% of the food intake and therefore knowledge of 
food consumption is a prerequisite for these studies (feed-back loop).
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The Joint FAO/WHO Expert Committee on Food Additives 
(JECFA, 2011) used this approach to calculate for example 
the chronic and acute exposure to DON and its acetylated 
derivatives. For chronic exposure, the average consumption 
data from 10 different regions (GEMS/food consumption 
cluster diets) were coupled with the weighted mean levels of 
DON and its acetyl metabolites in different food categories, 
and summed to obtain an overall estimate of the chronic 
exposure to DON and its acetyl metabolites per geographic 
region. In this example, for acute exposure, a wheat intake 
of 9 g/kg bw (around the P97.5) was coupled to a high 
mycotoxin level of 10 mg/kg wheat.
In point estimates, often conservative estimates of the input 
variables are applied, resulting in high-end estimation of 
the exposure. The main advantage of this approach is that 
it is easy to perform and often used for a first conservative 
risk identification.
Observed individual mean
With the observed individual mean approach, a mean 
mycotoxin concentration per food product is combined 
with the food consumption per day per consumer, averaged 
over the days available in the survey and, in most cases, 
divided by the individual’s body weight (Boon and Van 
der Voet, 2015). This results in the average exposure per 
kg bw per person per day. Results from a food monitoring 
study or a total diet study are used as input for mycotoxin 
concentration.
Table 2. Main characteristics of four well-established exposure assessments methodologies.
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Point 
estimate
FMS No No4 Individual food 
ingredients/products
+ –/++ Chronic and 
acute
Input: single concentration and 
consumption level per food
Output: one chronic or acute intake 
level (mean, high)
Easy to perform
TDS (chronic) 
combined 
with data 
from FCS
Yes Composite processed 
food products
–/+ ++/–
Observed 
individual 
mean
FMS No No4 Individual food 
ingredients/products
+ –/++ Chronic Input: distribution of consumption 
and mean concentration levels
Output: distribution of mean intake 
levels over all recording days per 
individual
Computer modelling
TDS combined 
with data 
from FCS
Yes Composite processed 
food products
–/+ ++/–
Probabilistic 
approach
FMS No No4 Individual food 
ingredients/products
+ –/++ Chronic and 
acute
Input: as Observed Individual Mean
Output: distribution of chronic 
intake, adjusted for within-
individual variation; distribution of 
acute intake per person
Computer modelling
TDS (chronic) 
combined 
with data 
from FCS
Yes Composite processed 
food products
–/+ ++/–
Duplicate 
diet
DDS Yes Yes Composite processed 
food products 
– ++ Chronic and 
acute
Input: duplicate portions of food
Output: measured intake per 
duplicate portion (individual 
exposure assessment)
1 FMS = Food Monitoring Study, TDS = Total Diet Study, DDS = Duplicate Diet Study.
2 Scope = number of mycotoxins included in one analysis method: + = multiple mycotoxins, – = one or few mycotoxins.
3 LOQ limit of quantification: range from ++ = very low, to – = relatively high; resulting in higher or lower number of numerical data.
4 Food processing can be taken into account via food processing factors.
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For chronic exposure, the mean concentration of 
mycotoxins is used, because in the long run it is unlikely that 
a consumer will always consume products with only high or 
only low levels. Typically, information on food consumption 
is available over a period of 2 to 7 days per individual. With 
this approach, a distribution of daily average exposures for 
different individuals within a population is generated. From 
this distribution the mean and median chronic exposure 
and upper percentiles (e.g. 95th or 97.5th) for that population 
can be estimated. This method is currently used by EFSA 
to assess the chronic exposure to food contaminants and 
additives (EFSA, 2012a,c; 2015c). In the case of chronic 
exposure to mycotoxins it was applied for ochratoxin A 
(EFSA, 2006), aflatoxins (EFSA, 2007), Alternaria toxins 
(EFSA, 2011a), T2/HT-2 toxins (EFSA, 2011b), zearalenone 
(EFSA, 2011c), ergot alkaloids (EFSA, 2012d), nivalenol 
(EFSA, 2013a), sterigmatocystin (EFSA, 2013b), DON 
(EFSA, 2013d), fumonisins (EFSA, 2014a) and beauvericin/
enniatins (EFSA, 2014b). Occurrence data from a total 
diet study were recently used by to assess the exposure 
of consumers in the Netherlands to 48 mycotoxins, 
including patulin, aflatoxins, ochratoxin A, fumonisins, 
zearalenone, trichothecenes, ergot alkaloids, Alternaria 
toxins, beauvericin and enniatins (Lopez et al., 2016a; 
Sprong et al., 2016a,b).
Probabilistic approach
With the use of the probabilistic approach, both the acute 
and chronic exposure via food can be estimated. The 
acute exposure is estimated by combining daily individual 
consumption patterns from a food consumption survey 
with randomly selected levels per food product from a 
databank with mycotoxin levels in individual samples. 
The resulting individual exposures per food product are 
summed to obtain the exposure per day and subsequently 
divided by the individual’s body weight. This procedure 
is repeated multiple times (Monte Carlo simulation) 
resulting in individual daily exposure estimates that 
reflect all plausible combinations of daily consumptions 
and concentrations in a population. The upper part of the 
distribution represents consumers with a high intake of 
the compound (high consumers), which is important for 
assessing the acute risk.
In the case of ergot alkaloids, which may exert acute toxic 
effects, EFSA combined individual consumption data with a 
high mycotoxin level (P95 or the mean of the upper quartile) 
for the four main contributing food groups and an average 
level for the remainder (EFSA, 2012d). By summing up the 
exposure per individual per day, a distribution of so-called 
‘acute’ exposure estimates was generated. Both the mean 
and P95 values for these distributions in the various food 
consumption surveys were calculated and used to assess 
acute risks. Since no individual mycotoxin levels in food are 
used in this study, this approach is merely a combination of 
the point estimate (fixed levels) and a probabilistic approach 
(distribution of consumption).
With the use of the probabilistic approach, also the chronic 
exposure can be estimated using statistical models which 
use the same input as the observed individual mean 
approach (see previous section). The largest uncertainty of 
the use of the observed individual mean approach to assess 
the long-term exposure is equalling the distribution of 
mean exposures over the person-days per person, typically 
two days, to the ‘true’ long-term exposure distribution of 
a given population. Given the limited number of person-
days present in a food consumption database per person 
and the variation in daily food consumption patterns 
within an individual, the distribution of mean exposures 
over individuals obtained with the observed individual 
mean approach will often be too wide in comparison to 
distributions of ‘true’ long term exposures (Goedhart et 
al., 2012). These distributions contain both the variation 
in exposure between individuals and between days for the 
same individual (the within individual variation), whereas 
for the long-run the variation within individuals is not 
relevant by definition (the long-term exposure distribution 
is the variation between individuals, not within individuals) 
(Boon and Van der Voet, 2015). Statistical models that 
separate these two sources of variation, and subsequently 
remove the within individual variation from the long-
term exposure distribution, have proven to be useful for 
the estimation of long-term exposure (Dodd et al., 2006; 
Hoffmann et al., 2002; Slob, 1993).
The resulting long-term exposure distribution will be less 
broad than the distribution obtained with the observed 
individual mean approach, resulting especially in lower 
estimates of the higher percentiles of exposure and higher 
estimates of the lower percentiles. For example, the mean 
exposure assessed over just two days is more variable than 
the mean exposure assessed over more (up to hundreds) 
days that constitute a longer period of time.
Dietary exposure using duplicate diet studies
In duplicate diet studies (described in detail in Section 
2) daily portions are analysed for the compound(s) in 
question, resulting in an actual exposure level per day for 
that individual. The food consumption data collected in 
accompanying food diaries can be used to evaluate the 
possible sources of exposure. When duplicate portions 
are collected on only one day per individual, these data 
can only be used to assess acute exposure. If duplicate 
portions are collected on multiple days, chronic exposure 
can be estimated by either averaging the exposure over 
the collection days per individual (see observed individual 
mean) or by removing the within individual variation using 
statistical models (see probability approach). Duplicate 
diets have been collected and analysed for estimating the 
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exposure to various mycotoxins, like aflatoxin B1, aflatoxin 
M1, ochratoxin A, trichothecenes, fumonisins and T-2/
HT-2 toxins (Bakker et al., 2009; Gilbert et al., 2001; Jekel 
and Van Egmond, 2014; Sizoo and Van Egmond, 2005).
4. Human biomonitoring studies
An alternative way to assess exposure to a compound 
is the use of biomarkers to quantify the internal dose. 
Characteristics of the data collection studies and 
subsequent exposure assessment strategy are mentioned 
in Table 3 and 4.
Exposure can be assessed by biomarkers of exposure. This 
includes the detection of the parent compound (mycotoxins) 
and/or its main phase I and phase II metabolites (e.g. 
glucuronide conjugates), measured in accessible body fluids 
(blood, urine) or body specimen (like hair). In contrast, 
biomarkers of effect can be used to assess the outcome after 
exposure to mycotoxins and include, e.g. changes in level 
of specific proteins (including diagnostic enzymes), cellular 
metabolites (metabolomics), or gene expression profiles 
(toxicogenomics) resulting from the specific alteration 
in metabolic or signalling pathways (Valencia-Quintana 
et al., 2014). Since these changes can also results from 
inter-individual differences, effects from other compounds 
in food or underlying diseases, it is difficult to link them 
exclusively to the intake of mycotoxins. Human biomarker 
research related to mycotoxins started in the early 1990’s 
to gain insight into the mechanisms of action of aflatoxin 
B1 and to control the outcome of intervention strategies. 
Aflatoxin M1 was the predominant biomarker of exposure, 
detected in milk and urine during exposure assessments 
(Gambacorta et al., 2013; Routledge et al., 2014). Changes in 
the sphingosine/sphinganine ratio were used as biomarker 
of exposure and effect for fumonisins (Eaton and Gallagher, 
1994; Gilbert et al., 2001; Guengerich et al., 1998; Mclean 
and Dutton, 1995; Shephard et al., 2007).
The measurement of biomarkers of exposure is the 
only available strategy that integrates exposure from all 
sources, (e.g. food, inhalation, skin contact) and reflects the 
internal biological active fraction (Choi et al., 2015). The 
exposure can be assessed by converting urinary mycotoxin 
concentrations to intake levels, taking into account their 
kinetics, such as rate of excretion (i.e. % of the ingested 
mycotoxins excreted as the parent compound or metabolites 
in urine), daily urine production (defined by e.g. creatinine) 
Table 3. Characteristics of: (1) study design; (2) sample number and analysis; (3) ethical issues; (4) costs; and (5) ability to use 
provided samples for other contaminants.
Data collection 
study
Characteristics
Human biomonitoring 
studies
1. Study design is complex; knowledge on relevant biomarkers and toxicokinetics is required.
2.  Collection and analysis involves handling of body fluids; high costs for sample preparation; standardised analytical methods not 
readily available; dedicated highly sensitive analysis required to achieve quantifiable results due to low concentrations in urine.
3. A representative group of reliable volunteers must be identified; ethical approval is required and privacy must be managed.
4. Relatively high analysis costs per sample/mycotoxin.
5.  Samples can be used for analysis of multiple contaminants; allows estimation of chronic and acute exposure to 
contaminants.
Table 4. Main characteristics of exposure assessments via biomarkers.
Exposure 
assessment 
strategy
Collection 
of data on 
mycotoxin 
contamination1
Volunteers 
involved in 
sampling
Takes consumer’s 
food processing 
into account
Typical 
samples 
analysed
Analysis 
method 
(scope)2
Analysis 
method 
(LOQ)3
Assessing 
chronic and/
or acute 
exposure
Characteristics 
of exposure 
assessment 
strategies
Human 
biomonitoring
HBS Yes Yes Urine, blood –/+ ++ Chronic and 
acute
Input: concentrations 
in biological fluids
Output: estimation of 
uptake or intake
1 HBS = human biomonitoring study.
2 Scope = number of mycotoxins included in one analysis method: + = multiple mycotoxins, – = one or few mycotoxins.
3 LOQ limit of quantification: range from ++ = very low, to – = relatively high; resulting in higher or lower number of numerical data.
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and body weight (Gratz et al., 2014; Rodriguez-Carrasco 
et al., 2014; Sarkanj et al., 2013; Solfrizzo et al., 2014; 
Turner et al., 2008; Wallin et al., 2013; Warth et al., 2012). 
This re-calculation is only possible for toxins showing a 
rapid elimination and short mean residence time (like for 
example DON). Since most of the toxicokinetic studies for 
mycotoxins have been performed in animals and specific 
data for humans are often lacking, exposure assessment 
using biomarkers of exposure is up to now a quantitative 
approach with high uncertainties.
Nevertheless, human biomonitoring was recently used to 
assess exposure of the Belgian population to the mycotoxins 
aflatoxins, citrinin, fumonisins, trichothecenes, ochratoxin 
A, zearalenone and their metabolites or modified forms 
(Heyndrickx et al., 2015). This study showed the very high 
prevalence of exposure to toxins such as DON. Moreover, 
citrinin was found in 50% of the urine samples while this 
mycotoxin was detected at only low levels and incidence in 
monitored food samples. This apparent discrepancy may 
result from variations in kinetic factors influencing the 
excretion of citrinin in humans, but may also indicate the 
need to identify as yet neglected sources of human citrinin 
exposure (Heyndrickx et al., 2015).
A human biomonitoring study may also give insight in the 
bioavailability of mycotoxins from unexpected or unknown 
sources and the presence of modified forms in food (e.g. 
glucosides, sulphates), which may become available for 
absorption after conversion to the parent compound in the 
gastrointestinal tract (EFSA, 2014a; Solfrizzo et al., 2014). 
These modified mycotoxins are those forms that may not 
be included in the currently applied analytical methods, 
partly since analytical standards and reference materials 
are not yet available or because the (modified) mycotoxins 
are not extracted with the applied methods.
In summary, although biomarkers for mycotoxin exposure 
can be measured in various biological fluids and tissues, 
such as (breast)milk, plasma, saliva, faeces, hair, nails, 
liver, kidneys or lungs, urine has become the preferred 
matrix (Sewram et al., 2001; Shephard et al., 2007). Human 
biomonitoring can identify vulnerable groups and can 
reduce the assumptions regarding consumption rates 
(Choi et al., 2015). Results of epidemiological studies on 
mycotoxins using biomonitoring have been reported in the 
past two decades (Duarte et al., 2012; Ediage et al., 2013; 
Gilbert et al., 2001; Pena et al., 2006; Rubert et al., 2011; 
Turner et al., 2010; Van der Westhuizen et al., 2011). These 
studies were based on only one urine sample per person, 
and thus the collection can be fairly easy (Heyndrickx et 
al., 2014; Solfrizzo et al., 2014). However, authors of a 
recent study, whereby the exposure to DON in three EU 
countries using these urinary biomarkers was assessed, 
strongly advice to collect 24-hours urine (Brera et al., 2015).
In order to compare the urinary concentrations within 
individuals, inter-individual variability in urine production 
needs to be circumvented. For this reason, urinary 
creatinine concentrations are widely used to adjust urinary 
concentrations of chemicals or their metabolites (Barr et 
al., 2005; Turner et al., 2010). Furthermore, the analysis of 
urine samples requires low LOQs, which can be reached 
by applying targeted analysis. Moreover, urine samples 
are usually treated with enzymes like β-glucuronidase/
sulfatase to convert conjugates into the parent compound 
(Solfrizzo et al., 2014). Costs for human biomonitoring 
studies are high due to the involvement of large numbers 
of volunteers, a complicated study design and sample 
collection. Analysis of the samples is costly. Finally, human 
biomonitoring involve volunteers and, therefore, ethical 
issues must always be addressed and a consensus of the 
volunteers is needed.
5. Comparison of the different approaches
Selection of the most suitable approach
In practice, a tiered approach can be used to estimate the 
exposure to mycotoxins within a population. In lower 
tiers, exposure estimates are based on limited data using 
a point estimate approach. When exposure seems to be 
significant, these estimates can be refined, in the case of 
chronic exposure using the observed individual mean 
and/or statistical methods for extrapolation to long-term 
exposure, and for acute exposure the probabilistic approach, 
resulting in the most accurate estimation of both types of 
intake (Pastoor et al., 2014).
Advantage of observed individual mean and probabilistic 
approaches is that the entire food consumption database, 
and food concentration data, is considered which results 
in more realistic exposure estimates of a given population 
(in a country of geographic region). This supports the 
derivation of a health-based guidance value and identifies 
segments of a population (such as children) with a higher 
risk. Another advantage is that also the uncertainty in 
the exposure estimations, caused by a limited size of the 
database, can be quantified (EFSA, 2012b).
The effects of food processing and preparation are included 
in total diet studies and in duplicate diet studies. This is 
of particular importance for less stable compounds, as 
otherwise exposure could be largely overestimated. An 
obvious limitation is the limited number of samples and the 
high costs and subject burden in duplicate diets studies. To 
illustrate this, in a duplicate diet study in the Netherlands 
into the exposure to T-2/HT-2 toxins covering several years, 
about 125 samples were collected per year (Jekel and Van 
Egmond, 2014). Subsequently, the duration of the duplicate 
diet studies is often limited to one day enabling acute, and 
much less for chronic, exposure assessment (Solfrizzo et al., 
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2014). Drawback of a total diet study is the required large 
amount of food items. To illustrate this, 1,617 single food 
items were included in a total of 88 composite samples in 
a total diet study on exposure to mycotoxins (Sprong et al., 
2016a). When assessing the exposure to mycotoxins using 
food consumption and food mycotoxin level data, effect 
of processing can be included by using processing factors.
Human biomonitoring is the only strategy that includes 
exposure from sources other than food, although this 
may be less relevant in the case of mycotoxins. Human 
biomonitoring requires a detailed understanding of the 
toxicokinetics in the human body which is still poorly 
understood for many mycotoxins. A clear advantage of 
biomarker studies is the estimation of the internal dose, 
determining the biological effects, and the identification of 
biomarkers that combine effect and exposure monitoring, 
such as DNA adducts of aflatoxins. Moreover, measuring 
the actual concentration in body fluids addresses the 
uncertainty of the existence of modified forms of mycotoxins 
that remain undetected by conventional analytical methods. 
Recently, EFSA concluded that glucosides of DON, nivalenol 
and zearalenone, and the hidden forms of fumonisins 
(EFSA, 2014a) may considerably contribute to the overall 
human exposure. In addition, EFSA proposed to apply 
relative potency factors for all known biologically active 
metabolites. This applies for example to zearalenone, as 
an equivalence factor of 60 needs to be considered for its 
metabolite α-zearalenol, in the derivation of health-based 
guidance levels (EFSA, 2016).
Emerging mycotoxins
Exposure assessments of mycotoxins that have no legal limit 
face some additional challenges. At the moment of data 
collection, it may not be clear which foods contribute most 
to the exposure, samples may not be well characterised, 
analytical reference standards or reference materials are 
lacking, method of analysis may not be harmonised or 
validated, LOQs required to exclude potential health risks 
are unknown (Mol et al., 2015), and the relation between 
intake and excreted metabolites is unknown. Analysis of 
long-time stored duplicate or total diets may overcome 
these problems to some extent, assuming all relevant 
consumed foods are collected. When new mycotoxins are 
discovered, or new analytical methods with lower LOQs 
become available, or when applying trend analyses, these 
stored samples can provide valuable information (Jekel and 
Van Egmond, 2014). Human biomonitoring studies may 
have little relevance in this situation if relevant biomarkers 
of emerging mycotoxins are not yet defined.
Trends in levels and exposure
Ideally, food consumption surveys are regularly updated, to 
assess changes in mycotoxin exposure in time. Trends like 
an increased consumption of breakfast cereals containing 
nuts may increase the exposure to mycotoxins present in 
nuts, such as aflatoxins and ochratoxin A. Results from 
monitoring studies can be used for analysing trends in 
mycotoxin occurrence in (raw) food materials and may 
lead to an updated exposure assessment. Significant 
increases in mycotoxin exposure, even if below the health-
based guidance value, can be detected, with subsequent 
identification of the source of the increased exposure and 
evaluation of measures for reduction.
6. Conclusions
Exposure assessments of mycotoxins are complicated since 
their concentrations in food: (1) are often heterogeneously 
distributed over the samples; (2) differ between geographic 
regions and production years; (3) can be affected by (food) 
processing and preparation; and (4) mycotoxins can be 
present in modified forms. Each of the five strategies 
for estimating the dietary exposure of a population to 
mycotoxins discussed in this paper has its merits and 
restrictions. The same applies to the studies collecting the 
data needed to perform these assessments. A combination 
of the different strategies has an added value for the risk 
assessment of mycotoxins, including the identification of 
unknown sources or modified forms.
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